About NephRx Corporation

About company

NephRx Corporation, a biotechnology company, engages in the discovery and development of therapeutic products for the treatment of acute kidney failure, renal disorders, and diseases of the gastrointestinal tract. It provides NX001, which is useful for the treatment of delayed graft function in kidney transplant patients; and NX002, a peptide that is derived from the naturally occurring growth factor AMP-18. The company was incorporated in 1995 and is based in Kalamazoo, Michigan.